ERK INHIBITORS

The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and a pharmaceut...

Full description

Saved in:
Bibliographic Details
Main Authors LIU, Ziping, BOYCE, Christopher, KARUNAKARAN, Ganesh Babu, GUERIN, David, WITTER, David, LIU, Wei, SILIPHAIVANH, Phieng, SLOMAN, David, L, HUANG, Xianhai, LIM, Jongwon, MOLINARI, Danielle, ZHOU, Hua, WAN, Zhilong, BAKSHI, Raman Kumar, METHOT, Joey, FU, Jianmin, LIPFORD, Kathryn Ann
Format Patent
LanguageEnglish
French
German
Published 30.10.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and a pharmaceutically acceptable carrier. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and an effective amount of at least one other pharmaceutically active ingredient (such as, for example, a chemotherapeutic agent), and a pharmaceutically acceptable carrier.
Bibliography:Application Number: EP20150870725